China PIPERAZINE 3HCL Factory

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for PIPERAZINE 3HCL,CAS NO 1621519-77-4,1621519-77-4,Gilteritinib intermediate,Gilteritinib advance intermediate, We have been prepared to offer you the top suggestions on the designs of one's orders in a professional way if you need. During the meantime, we retain on developing new technologies and building new designs so as for making you ahead within the line of this business.
PIPERAZINE 3HCL, We believe in establishing healthy customer relationships and positive interaction for business. Close cooperation with our customers has helped us to create strong supply chains and reap benefits. Our products and solutions have gained us widespread acceptance and the satisfaction of our worldwide valued clients.

Hot Products

  • Sodium trifluoromethanesulfinate

    Sodium trifluoromethanesulfinate

    Product Name:Sodium trifluoromethanesulfinate
    Molecular Formula:CH2F3NaO2S
    Molecular Weight:158.07
    CAS Registry Number:2926-29-6
  • 7,10-di-Troc-Docetaxel

    7,10-di-Troc-Docetaxel

    Product Name:7,10-di-Troc-Docetaxel
    Molecular Formula:C49H55Cl6NO18
    Molecular Weight:1158.67
    CAS Registry Number:114915-14-9
  • Calcium stearate

    Calcium stearate

    Product Name:Calcium stearate
    Molecular Formula:C36H70CaO4
    Molecular Weight:607.02
    CAS Registry Number:1592-23-0
  • Mirabegron

    Mirabegron

    Product Name:Mirabegron
    Molecular Formula:C21H24N4O2S
    Molecular Weight;396.51
    CAS Registry Number;223673-61-8
  • 6-Bromoquinoline

    6-Bromoquinoline

    Product Name:6-Bromoquinoline
    Molecular Formula:C9H6BrN
    Molecular Weight:208.05
    CAS Registry Number:5332-25-2
  • Nandrolone

    Nandrolone

    Product Name:Nandrolone
    Molecular Formula:C18H26O2
    Molecular Weight:274.4
    CAS Registry Number;434-22-0

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept